Collaborative Persons definition

Collaborative Persons means (i) employees, officers, and directors of Provider of Medical Services, including without limitation the Principal Investigator, and (ii) any agents, contractors or other third parties approved by Sponsor in writing in accordance with Article 15. In the event that Principal Investigator leaves or is removed from the Provider Smluvní strany se dohodly následovně: 1.
Collaborative Persons means (i) employees of Provider who participate in the Study. In the event that Principal Investigator leaves or is removed from the Provider, then Provider shall, within ten (10) days of becoming aware of such departure by Principal Investigator, provide written notice of such event to Sponsor. Any successor to Principal Investigator must be approved, in writing, by Xxxxxxx and such successor shall be required to agree to all the terms and conditions of the Protocol and this Agreement and to sign each such document as evidence of such agreement (although failure to so sign will not relieve such successor from abiding with all the terms and conditions of the Protocol and this Agreement). Provider represents and warrants that it will not use in any capacity, in connection with any services to be performed under this Agreement, any individual whom Smlouvy jako její Příloha A, Poskytovatel osvědčuje, že podle jeho nejlepšího vědomí, jsou jeho zařízení a populace subjektů hodnocení vhodné pro provedení Studie předpokládané touto Smlouvou a Protokolem. Poskytovatel a Hlavní zkoušející souhlasí, že veškeré aspekty této Studie budou provedeny v souladu se všemi příslušnými právními předpisy České republiky, zejména zákonem č. 378/2007 Sb., o léčivech a o změnách některých souvisejících zákonů (zákon o léčivech) (xxxx xxx „Zákon léčivech“), zákonem č. 372/2011 Sb., o zdravotních službách a podmínkách jejich poskytování, v platném znění, včetně prováděcích předpisů k těmto zákonům (zejména vyhláškou č. 226/2008 Sb., kterou se stanoví správná klinická praxe a bližší podmínky klinického hodnocení léčiv), Mezinárodní konferencí o harmonizaci technických požadavků na registraci humánních léčivých přípravků Správná klinická praxe: Konsolidovaná směrnice (the International Conference on Harmonisation of Technical Requirements for Registration of

Examples of Collaborative Persons in a sentence

  • If information collected on the form changes during the course of the Study or within one year after the last subject has completed the Study as specified in the Protocol, Principal Investigator and the other applicable Collaborative Persons are required to inform Sponsor of such change.

  • Principal Investigator and Provider of Medical Services shall provide all of the services contemplated herein through fully trained and competent Collaborative Persons (as defined below) having a skill level appropriate for the tasks assigned to them and shall ensure that all Collaborative Persons (as defined below) comply with the terms of this Agreement and the Protocol.

  • Provider of Medical Services will cause Principal Investigator or other applicable Collaborative Persons such as subinvestigators to complete a certification and disclosure form concerning financial interests or other conflicts of interests they may have related to the Study or Sponsor.

  • Provider of Medical Services and Principal Investigator shall limit disclosure of Confidential Information received hereunder to only those of its Collaborative Persons who are bound by a written agreement with terms equivalent to or more stringent than this Agreement and who are directly involved with the Study and only on a need to know basis.

  • Connor from the Social Ministry Committee at St. Martin de Porres Parish at St. Mary’s.Motion 6-0.

  • Provider of Medical Services and Principal Investigator shall advise its Collaborative Persons upon disclosure to them of any Confidential Information of the proprietary nature thereof and the terms and conditions of this Agreement and shall use all reasonable safeguards to prevent unauthorized use or disclosure by such Collaborative Persons.

  • Principal Investigator and Provider shall provide all of the services contemplated herein through fully trained and competent Collaborative Persons (as defined below) having a skill level appropriate for the tasks assigned to them and shall ensure that all Collaborative Persons (as defined below) comply with the terms of this Agreement and the Protocol.

  • Provider will cause Principal Investigator or other applicable Collaborative Persons to complete a certification and disclosure form concerning financial interests or other conflicts of interests they may have related to the Study or Sponsor.

  • Provider and Principal Investigator shall limit disclosure of Confidential Information received hereunder to only those of its Collaborative Persons who are bound under a duty of confidentiality to Institution and whom Institution shall ensure such person’s agreement and compliance with the confidentiality terms of this Agreement, and who are directly involved with the Study and only on a need to know basis.

  • Syrian Arab Republic) said that the minimum age for marriage was currently 17 for girls and 18 for boys.

Related to Collaborative Persons

  • Collaboration has the meaning set forth in Section 2.1.

  • Collaborative matter means a dispute, transaction, claim, problem, or issue for resolution, including a dispute, claim, or issue in a proceeding, that is described in a collaborative law participation agreement and arises under the family or domestic relations law of this state, including any of the following:

  • Collaborating physician means the physician who,

  • Research Program has the meaning set forth in Section 3.1.

  • Collaborative lawyer means a lawyer who represents a party in a collaborative law process.

  • Collaborative agreement means a voluntary, written, or electronic arrangement between one

  • Research Program Term has the meaning set forth in Section 2.2.

  • Collaboration Term has the meaning set forth in Section 2.1(h).

  • Competing Program has the meaning set forth in Section 8.5.

  • Joint Steering Committee or “JSC” has the meaning set forth in Section 3.1.

  • Collaboration IP means Collaboration Know-How and Collaboration Patents.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Steering Committee shall have the meaning set forth in Section 3.1.

  • Joint Research Committee or “JRC” has the meaning set forth in Section 3.1.1.

  • Research Plan shall have the meaning set forth in Section 2.1.

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Development Team means the entities and professionals assembled to develop and manage the Project, typically including the Applicant, Owner, Developer(s), Co-Developer(s) and general partner or any other related entities in which the Developer or Co-Developer has an identity of interest or a Controlling Interest.

  • JSC has the meaning set forth in Section 3.1.

  • Collaborative practice means that a physician may delegate aspects of drug therapy management for the physician’s patients to an authorized pharmacist through a community practice protocol. “Collaborative practice” also means that a P&T committee may authorize hospital pharmacists to perform drug therapy management for inpatients and hospital clinic patients through a hospital practice protocol.

  • Project Steering Committee or “PSC” means the committee referred to in Section I.B of Schedule 2 to this Agreement;

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Competing Products means any product or service in existence or under development that competes with any product or service of the Company Group about which the Participant obtained Confidential Information or for which the Participant provided advisory services or had sales, origination, marketing, production, distribution, research or development responsibilities in the last twenty-four (24) months of employment with the Company Group.

  • Development Program means the implementation of the development plan.

  • Collaboration Technology means all Collaboration Patents and Collaboration Know-How.

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).